A Framework for Evaluating the Clinical Consequences of Initial Therapy with NSAIDs, NSAIDs plus Gastroprotective Agents, or Celecoxib in the Treatment of Arthritis-Reference-Cited by-同舟云学术

A Framework for Evaluating the Clinical Consequences of Initial Therapy with NSAIDs, NSAIDs plus Gastroprotective Agents, or Celecoxib in the Treatment of Arthritis

Published:2001 Issue:Supplement 1 Volume:19 Page:33-47
ISSN:1170-7690
Container-title:PharmacoEconomics
language:en
Short-container-title:PharmacoEconomics

Author:

Burke Thomas A.,Zabinski Richard A.,Pettitt Daniel,Maniadakis Nikos,Maurath Clement J.,Goldstein Jay L.

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Reference66 articles.

1. Gastrointestinal Tract Complications of Nonsteroidal Anti-inflammatory Drug Treatment in Rheumatoid Arthritis

2. Pharmacoeconomics of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

3. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study

4. Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness Analyses of Osteoarthritis Oral Therapies: a Systematic Review;Applied Health Economics and Health Policy;2013-11-09

2. Cost-Utility Analysis of Duloxetine in Osteoarthritis: A US Private Payer Perspective;Applied Health Economics and Health Policy;2013-04-25

3. Evaluación económica de tramadol/paracetamol en el manejo del dolor en pacientes con osteoartrosis en España;Reumatología Clínica;2011-07

4. Economic evaluation of tramadol/paracetamol in the management of pain in patients with osteoarthritis in Spain;Reumatología Clínica (English Edition);2011-01

5. Are COX-2 inhibitors preferable to combined NSAID and PPI in countries with moderate health service expenditures?;Journal of Evaluation in Clinical Practice;2010-12